UK markets closed

Collegium Pharmaceutical, Inc. (COLL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
36.42+0.58 (+1.62%)
At close: 04:00PM EDT
36.42 0.00 (0.00%)
After hours: 05:32PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.19B
Enterprise value 1.55B
Trailing P/E 28.23
Forward P/E 5.89
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.69
Price/book (mrq)6.09
Enterprise value/revenue 2.74
Enterprise value/EBITDA 5.04

Trading information

Stock price history

Beta (5Y monthly) 1.04
52-week change 358.42%
S&P500 52-week change 322.36%
52-week high 340.95
52-week low 320.83
50-day moving average 337.04
200-day moving average 328.68

Share statistics

Avg vol (3-month) 3410.54k
Avg vol (10-day) 3327.98k
Shares outstanding 532.71M
Implied shares outstanding 632.71M
Float 828.8M
% held by insiders 11.41%
% held by institutions 1121.08%
Shares short (15 Apr 2024) 46.99M
Short ratio (15 Apr 2024) 414.42
Short % of float (15 Apr 2024) 426.40%
Short % of shares outstanding (15 Apr 2024) 421.36%
Shares short (prior month 15 Mar 2024) 47.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 8.50%
Operating margin (ttm)41.19%

Management effectiveness

Return on assets (ttm)10.28%
Return on equity (ttm)24.68%

Income statement

Revenue (ttm)566.77M
Revenue per share (ttm)16.80
Quarterly revenue growth (yoy)15.50%
Gross profit (ttm)N/A
EBITDA 339.83M
Net income avi to common (ttm)48.16M
Diluted EPS (ttm)1.29
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)310.55M
Total cash per share (mrq)9.72
Total debt (mrq)674.28M
Total debt/equity (mrq)345.02%
Current ratio (mrq)1.17
Book value per share (mrq)6.13

Cash flow statement

Operating cash flow (ttm)274.75M
Levered free cash flow (ttm)274.32M